Wednesday, August 26, 2026

Commodities & Fixed Income

2 articles

CME FedWatch Hits 50% Rate-Hike Odds as Warsh Fed Confronts Iran War Oil Shock and Yield Surge

CME FedWatch Hits 50% Rate-Hike Odds as Warsh Fed Confronts Iran War Oil Shock and Yield Surge

CME FedWatch now prices a 50% probability of a Federal Reserve rate hike — the first meaningful tightening signal in years. Kevin Warsh inherits the chair as Iran War-driven oil prices, surging Treasury yields, and a global debt selloff force markets to reprice Fed policy. The May 28 PCE print is the next inflection point for rate derivatives, commodity hedges, and fixed-income positioning.

LM Salvado
Oil Above $80 Triggers Gilt Sell-Off as UK Fiscal Strain Collides with US Social Security Crisis

Oil Above $80 Triggers Gilt Sell-Off as UK Fiscal Strain Collides with US Social Security Crisis

Oil prices above $80 driven by Iranian conflict are triggering gilt market pressure ahead of the UK Spring Statement, while the US faces Social Security insolvency by 2032—four years earlier than projected—as tax cuts threaten trillions in federal revenue. The dual fiscal crises arrive as Fed Chair Jerome Powell's May 2026 departure looms, creating policy uncertainty across both economies.

ViaNews Editorial Team (Markets)
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com